• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Abbott recalls 550 Powersail catheters

UPDATE: Abbott recalls 550 Powersail catheters

July 30, 2009 By MassDevice staff

Abbott Vascular issued a voluntary recall of four lots of its Powersail coronary dilation catheter after it received reports of damaged distal shafts.

Three of the four complaints, one for each lot, did not involve what the company called “adverse patient effects.” However, one complaint showed evidence that the patient suffered a post-procedure heart attack, but was subsequently said to be “doing well,” according to a press release.

Abbott spokesman Jonathon Hamilton told MassDevice that the total number of catheters in all four lots numbers about 550.

“Most of them had already been successfully used and all the outstanding products that hadn’t been used are accounted for,” Hamilton said, adding that Abbott initiated the recall several weeks ago.

The defect in the lots affected by the recall — three in the U.S. and one distributed internationally — can be detected and avoided before the catheters are used, but if undetected might cause contrast material to leak. That, in turn, could lead to “catheter functional failures and clinical consequences, including air embolism and myocardial infarction, which has the potential to lead to death,” according to the press release.

Sales reps for the Abbott Park, Ill.-based company have already contacted all customers affected by the recall and all units are either back in Abbott’s hands or on their way. Patients who have already been treated using the Powersail catheter are not affected by the recall.

The Food & Drug Administration labeled the action as a Class I recall, its highest recall level, indicating that the product in question could seriously injure or kill people.

The affected lots are as follows:

Product Designation Product Number Lot
Number
Expiration Date
POWERSAIL® 3.25x18mm (U.S.)

1005524-18

7101051

09-2009

POWERSAIL® 4.0x8mm (CE)

1005726-08

7112051

10-2009

POWERSAIL® 2.75x18mm (U.S.)

1005522-18

8012151

12-2009

POWERSAIL® 3.25x8mm (U.S.)

1005524-08

8053061

04-2010

Concerned customers should call their Abbott Vascular rep or the company at 1-800-227-9902; any adverse reactions and quality problems should also be reported to the FDA’s MedWatch Program at 1-800-FDA-1088 or on the MedWatch website at www.fda.gov/medwatch.

Filed Under: Business/Financial News, Catheters

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy